AARDVARK THERAPEUTICS, INC. (AARD) Operating cash flow 2024–2025
AARDVARK THERAPEUTICS, INC. (AARD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$54.2MFY2025 · since FY2024: -$18.1M → -$54.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.2M | -199.5% |
| FY2024 | -$18.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice